The purpose of this study is to compare the usual approach (i.e. no more treatment or additional post-operative chemotherapy), to any effects, good and/or bad, of the experimental drug MK-3475 (also called pembrolizumab) after surgery.
This study will allow the researchers to know whether treatment with MK-3475 (pembrolizumab) is better, the same, or worse than the usual approach. There will be about 1,000 people taking part in this study across all research sites.
For more information please visit the National Cancer Institute.
LOCATIONS:
1. Genesis Cancer Care Institute
1401 W. Central Park Ave.
Davenport, IA 52804
Phone Number: 563-421-1900
2. Genesis Cancer Clinic-Silvis
801 Illini Dr.
Silvis, IL 61282
Phone Number: 563-421-1900
3. Iowa Cancer Specialists
1750 E. 53rd St.
Davenport, IA 52807
Phone Number: 563-345-4325
